Pharmacists as mid-level healthcare providers and the clinical results of a pharmacist-led diabetes disease management program.

[摘要] Advancements in medical therapy have augmented resources available tophysicians to treat disease and, because of this, spending on prescription drugshas doubled in the past decade. Increasingly, clinical trials are demonstrating thebenefits of aggressive disease management in reducing morbidity and mortality.Physicians treating patients with chronic conditions must balance the benefits ofcombination drug therapy against the risk of adverse drug events and druginteractions. For instance, evidence-based practice guidelines in patients withdiabetes and multiple comorbidities require combination therapy in order toreduce morbidity and mortality. Patients with polymorbidity require the attentionof multiple physicians, further fragmenting patient care and increasingpolypharmacy related issues. Pharmacists are increasingly recognized forexpertise in pharmacodynamics and pharmacokinetics and have been shown tobe beneficial when utilized in patient care. Pharmacists are in a key position tohelp physicians manage the balance between optimal disease management andthe risks of polypharmacy.

[发布机构] University:University of Louisville;Department:Pharmacology and Toxicology

[效力级别] Pharmacy

[关键词] Diabetes;Pharmacy;Asheville